Targeting the transforming growth factor-beta signaling pathway in human cancer.
about
Interaction of tumor cells with the microenvironmentEffector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseMolecular concept in human oral cancerClinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathwayDEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticityMolecular aspects of development and regulation of endometriosisNeuraminidase-1: a novel therapeutic target in multistage tumorigenesisTGF-β signaling and its targeting for glioma treatmentMolecular Aspects of Head and Neck Cancer TherapyTransforming growth factor β signaling overcomes dasatinib resistance in lung cancerGinsenoside Rd attenuates breast cancer metastasis implicating derepressing microRNA-18a-regulated Smad2 expressionSynthesis and SAR of b-annulated 1,4-dihydropyridines define cardiomyogenic compounds as novel inhibitors of TGFβ signaling.DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionTwo faces of TGF-beta1 in breast cancer.Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signalingEpithelial-mesenchymal transition in prostate cancer: an overview.TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease.Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedbD-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implicationsElucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell linesChemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.TGFβ Pathway Inhibition Redifferentiates Human Pancreatic Islet β Cells Expanded In VitroA High-Throughput Screening Platform Targeting PDLIM5 for Pulmonary Hypertension.Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signalingIntravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host.Interface between breast cancer cells and the tumor microenvironment using platelet-rich plasma to promote tumor angiogenesis - influence of platelets and fibrin bundles on the behavior of breast tumor cells.MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC.An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.Histopathological Characteristics of Post-inflamed Coronary Arteries in Kawasaki Disease-like Vasculitis of Rabbits.Association between transforming growth factor-β1 expression and the clinical features of triple negative breast cancer.Effects of Two Common Promoter Polymorphisms of Transforming Growth Factor-β1 on Breast Cancer Risks in Ahvaz, West South of IranMetformin is a novel suppressor for transforming growth factor (TGF)-β1Effects for Sequential Treatment of siAkt and Paclitaxel on Gastric Cancer Cell Lines.Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma.Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impactThe polarization of immune cells in the tumour environment by TGFbeta.
P2860
Q21245506-2FD68857-1B11-4E86-987B-8185793B6EBCQ26744527-94C9B46D-8627-4252-AEC4-E53A51211722Q26775850-29B8955A-3ABB-4A69-BCC4-059C839CB484Q26797238-E5408CE1-A05F-45B9-8A76-746C206F276CQ26825789-041C36D9-AD72-48B1-BB1A-84747F99F01DQ26865356-89062838-7A52-42DE-860C-500B4EDB8ADFQ28066130-CA981803-B05D-4F45-8FEA-EF3DCCE7ADC8Q28082042-9DC3EF79-2F49-4DDD-9894-25521AAB15D8Q28082815-B7EFF6D7-E73C-4170-A1D6-832B5B1EDAF2Q28542671-5E6FF1DA-9917-4F06-8D40-3DCDBF499D56Q28829940-E7D0FD5B-B340-4C49-BC88-A97F8EF43A9CQ30529635-671EBE13-7F60-41CA-A3D5-D9A2E5B29224Q30584686-53A06583-7807-4CDA-BDE2-983347D8B1EAQ33661529-C42777E9-42DD-42AA-B180-DF6D46C2BBA0Q33690926-8A5DCCAC-270C-4173-ADA3-FBECBB273574Q33728145-6E6B6045-3CBA-4B5B-AB4C-A0B1BB91371CQ33798864-C65C0E06-AD01-45F1-B2F2-274893300C48Q34133221-5D92C8A1-6BF2-4C5C-8081-42AB5153CE6FQ34178740-CF20352A-2824-4F19-8EF7-691611A6A192Q34487585-3AF31F06-D706-4B61-8D07-49990A5C5AE9Q34537320-E6E45E33-A0C5-46BA-8416-91DE22BADA55Q35108319-E3F3C84A-EA03-42E1-B87C-959CEF6D69E4Q35328276-6AD77B14-7B25-438A-A315-3BB1922E3BF3Q35444302-F88FD9A8-E36D-4A2D-A357-EE5C1B8C4C91Q35490960-0219C155-0D61-4EE9-BE2B-F1F4DA5556C7Q35791836-C55F9C8D-F64D-4935-9D27-5A88844312A8Q35893117-FAD89495-4AA1-4D61-87F2-9EE016B86CB5Q36140792-EC90EDB4-E3FA-46A0-88E9-C6755516B5B9Q36179390-BA4C0BA5-65E3-432F-AE9F-FF3983E92485Q36277239-F15E460A-2B07-4685-BFD0-213248D8886EQ36333514-A88314A7-A811-4EF9-B33F-0CE1172DC10EQ36545124-460EF908-3AEB-4F7B-9017-7E35204AC3C2Q36693693-608FE7BE-63E3-46A5-A9A1-43F9B78846CEQ36954265-FE69BEDB-BCFD-4CD5-B6C3-3DF2FDE5C9C7Q37040855-0E7675BF-71F2-4BA8-90A0-DA12097E62B6Q37044398-7874BD2D-B104-4036-BB05-42CFE5D5E97AQ37263512-EC5BDCCC-F57E-4299-ABD8-FFDAEBBCFC64Q37337989-0E453F76-376B-4FDB-A358-AF5B418AD900Q37348262-3E990B2F-F5F0-452A-A8C2-BC75F3CEB645Q37454364-DDD18417-6141-422F-8CE5-532FBA782EF5
P2860
Targeting the transforming growth factor-beta signaling pathway in human cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@ast
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@en
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@nl
type
label
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@ast
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@en
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@nl
prefLabel
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@ast
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@en
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@nl
P2860
P1476
Targeting the transforming growth factor-beta signaling pathway in human cancer.
@en
P2093
Nagathihalli S Nagaraj
Pran K Datta
P2860
P356
10.1517/13543780903382609
P407
P577
2010-01-01T00:00:00Z